We are monitoring the impact of COVID-19 on Latin America Sepsis Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2829
Share on
Share on

Latin America Sepsis Diagnostics Market Research Report – Segmented By Pathogen, Product, Technology, Method, Usability, & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2829
Pages: 145

Latin America Sepsis Diagnostics Market Size (2021 to 2026)

The sepsis diagnostics market in Latin America is valued at USD 50.91 Million in 2021 and is estimated to be growing at a CAGR of 8.92% to reach USD 78.04 Million by 2026.

The growing burden of infectious diseases and increased sepsis incidence in Latin American countries are majorly pushing the market growth. According to WHO, sepsis affects around 30 million people, and also an estimated 6 million are dying every year. The market participants in this region have numerous opportunities to maximize their market share by developing and launching their advanced rapid tests. The growing aging population, the high R&D investments by the market participants in this regional market for the new tests, treatments, and intercessions to detect, treat, and prevent diseases. Initial detection of sepsis in patients has become essential, which is a positive signal for market growth. Growing demand for antibiotic-resistant bacterial strains, rising cases of neonatal umbilical cord infection is favoring the market.

Lack of standard protocols, shortage, experienced staff, and lack of awareness are likely to hinder the market growth to a small extent. Further, the market growth is estimated to get hampered by the poor healthcare infrastructure, the high costs associated with the treatments.

This research report on the Latin American sepsis diagnostics market has been segmented and sub-segmented into the following categories:

By Pathogen:

  • Bacterial Sepsis    
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
  • Fungal Sepsis        
  • Other Pathogen Infections

By Product:

  • Instruments          
  • Blood Culture Media          
  • Assay Kits & Reagents       
  • Software  

By Technology:

  • Microbiology         
  • Molecular Diagnostics       
  • Immunoassays    
  • Flow Cytometry  
  • Other Technologies

By Method:

  • Conventional Diagnostics
  • Automated Diagnostics

By Usability:

  • Laboratory Testing              
  • Point-of-Care Testing

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The Latin American sepsis diagnostics market is expected to have a steady growth rate during the forecast period. Mexico, Argentina, Peru, Chile, and other Latin American countries are included in the market. For example, according to a PubMed study, late sepsis onset is one of the leading causes of death among low-birth-weight infants in Chile. Additionally, the market for sepsis diagnostics in the region is primarily driven by regional alliances working to combat sepsis sickness.

The Instituto Latino Americano de Sepse convened a meeting for officials from Latin American countries to discuss sepsis-related issues. Furthermore, following the WHO decision, it is focused on exploring how to combat sepsis in these nations. As a result, such critical aspects are projected to propel the sepsis diagnostics market forward in the following decade.

In Brazil, the prevalence of sepsis has risen dramatically over time. One of the leading causes of death among sepsis patients in this region is a lack of resources. The demand for sepsis diagnostics is increasing due to some healthcare professionals taking initiatives to address the issues of sepsis. As a result, such factors are expected to boost the sepsis diagnostics market in Brazil over the forecast period.

The sepsis diagnostics market in Mexico and Argentina is likely to grow rapidly. Various activities by various organizations are expected to raise awareness about the disease and increase demand for its diagnosis solutions, accelerating market growth—the increasing prevalence of hospital-acquired infections and chronic disorders such as renal and liver disease fuels market expansion.

KEY MARKET PLAYERS:

Companies playing a key role in the Latin American sepsis diagnostics market profiled in the report are bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Pathogen                    

                                5.1.1 Introduction           

                                5.1.2 Bacterial Sepsis     

                                                5.1.2.1 Gram-Negative Bacterial Sepsis

                                                5.1.2.2 Gram-Positive Bacterial Sepsis

                                5.1.3 Fungal Sepsis         

                                5.1.4 Other Pathogen Infections              

                                5.1.5  Y-o-Y Growth Analysis, By Pathogen           

                                5.1.6  Market Attractiveness Analysis, By Pathogen         

                                5.1.7  Market Share Analysis, By Pathogen          

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Instruments           

                                5.2.3 Blood Culture Media           

                                5.2.4 Assay Kits & Reagents        

                                5.2.5 Software  

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Technology                 

                                5.3.1 Introduction           

                                5.3.2 Microbiology          

                                5.3.3 Molecular Diagnostics        

                                5.3.4 Immunoassays      

                                5.3.5 Flow Cytometry    

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8  Market Attractiveness Analysis, By Technology     

                                5.3.9  Market Share Analysis, By Technology       

                5.4 Method                       

                                5.4.1 Introduction           

                                5.4.2 Convential Diagnostics       

                                5.4.3 Automated Diagnostics     

                                5.4.4 Y-o-Y Growth Analysis, By Method               

                                5.4.5  Market Attractiveness Analysis, By Method            

                                5.4.6  Market Share Analysis, By Method             

                5.5 Usability                       

                                5.5.1 Introduction           

                                5.5.2 Laboratory Testing               

                                5.5.3 Point-of-Care Testing         

                                5.5.4 Y-o-Y Growth Analysis, By Usability              

                                5.5.5 Market Attractiveness Analysis, By Usability            

                                5.5.6 Market Share Analysis, By Usability              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Pathogen

                                                6.1.3.3 By Product

                                                6.1.3.4 By Technology

                                                6.1.3.5 By Method

                                                6.1.3.6 By Usability

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Pathogen

                                                6.1.4.3 By Product

                                                6.1.4.4 By Technology

                                                6.1.4.5 By Method

                                                6.1.4.6 By Usability

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Pathogen

                                                6.1.5.3 By Product

                                                6.1.5.4 By Technology

                                                6.1.5.5 By Method

                                                6.1.5.6 By Usability

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 bioMérieux SA                          

                                8.1.1 Overview 

                                8.1.2 Pathogen Analysis               

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 T2 Biosystem Inc                      

                8.3 Cepheid                       

                8.4 Thermo Fisher Scientific Inc.                               

                8.5 Nanosphere Inc                        

                8.6 Abbott Laboratories                               

                8.7 Roche Diagnostics Limited                    

                8.8 Becton, Dickinson and Company                       

                8.9 Bruker Corporation                 

                8.10 Beckman Coulter, Inc                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  2. Latin America Bacterial Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  3. Latin America Fungal Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  4. Latin America Other Pathogen Infections Market By Region, From 2021 to 2026 (USD Million)
  5. Latin America Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  6. Latin America Instruments Market By Region, From 2021 to 2026 (USD Million)
  7. Latin America Blood Culture Media Market By Region, From 2021 to 2026 (USD Million)
  8. Latin America Assay Kits and Reagents Market By Region, From 2021 to 2026 (USD Million)
  9. Latin America Software Market By Region, From 2021 to 2026 (USD Million)
  10. Latin America Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  11. Latin America Molecular Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  12. Latin America Microbiology Market By Region, From 2021 to 2026 (USD Million)
  13. Latin America Immunoassay Market By Region, From 2021 to 2026 (USD Million)
  14. Latin America Flow Cytometry Market By Region, From 2021 to 2026 (USD Million)
  15. Latin America Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  16. Latin America Conventional Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  17. Latin America Automated Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  18. Latin America Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  19. Latin America Laboratory Testing Market By Region, From 2021 to 2026 (USD Million)
  20. Latin America Point-of-Care Testing Market By Region, From 2021 to 2026 (USD Million)
  21. Brazil Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  22. Brazil Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  23. Brazil Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  24. Brazil Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  25. Brazil Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  26. Argentina Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  27. Argentina Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  28. Argentina Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  29. Argentina Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  30. Argentina Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  31. Mexico Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  32. Mexico Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  33. Mexico Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  34. Mexico Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  35. Mexico Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  36. Rest of Latin America Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  37. Rest of Latin America Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  38. Rest of Latin America Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  39. Rest of Latin America Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  40. Rest of Latin America Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample